Participants must meet eligibility criteria in the A1D-MC-ATMP screening protocol before entry into the treatment study.
To qualify as a participant of first-generation Japanese origin, the participant, the participant's biological parents, and all the participant's biological grandparents must be of exclusive Japanese descent and born in Japan.
To qualify as Chinese for this study, all four of the participant's biological grandparents must be of exclusive Chinese descent and born in China.
You may not be if
Have a condition that predisposes the participant to an infection.
Have a current or recent acute, active infection.
Have active tuberculosis (TB), have or have had latent TB.
Are receiving therapeutic antibodies or expected to initiate treatment with therapeutic antibodies during the study.
Clareo Health | A Study of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease (AD)
